TrialBlood advances2026

Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.

Johnny Mahlangu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.